Clinical Outcomes and Risk Factors for Death in Critically Ill Patients with Carbapenem-Resistant Klebsiella pneumoniae Treated with Ceftazidime-Avibactam: A Retrospective Study-Reference-Cited by-同舟云学术

Clinical Outcomes and Risk Factors for Death in Critically Ill Patients with Carbapenem-Resistant Klebsiella pneumoniae Treated with Ceftazidime-Avibactam: A Retrospective Study

Published:2024-01 Issue: Volume:Volume 17 Page:239-248
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Zhang Lingchun,Ma Yani,Zhao Chenglong,Zhao Shujuan,Zhao Lulu,Yang Yuxin,Wang Yuhan,Meng Haiyang^ORCID,Sun Jun

Publisher

Informa UK Limited

Reference35 articles.

1. Global Prevalence of Nosocomial Multidrug-Resistant Klebsiella pneumoniae: A Systematic Review and Meta-Analysis

2. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace

3. Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012

4. Analysis of the clinical application of ceftazidime-avibactam in China

5. Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosing Evaluation of Ceftazidime–Avibactam in Intensive Care Unit Patients Based on Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling and Simulation;Antibiotics;2024-09-09

2. Efficacy of lyophilized Lactobacillus sakei as a potential candidate for preventing carbapenem-resistant Klebsiella infection;Annals of Microbiology;2024-08-09

3. Clinical outcomes and risk factors for mortality in recipients with carbapenem-resistant gram-negative bacilli infections after kidney transplantation treated with ceftazidime-avibactam: a retrospective study;Frontiers in Cellular and Infection Microbiology;2024-05-08